JP2002541800A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002541800A5 JP2002541800A5 JP2000611669A JP2000611669A JP2002541800A5 JP 2002541800 A5 JP2002541800 A5 JP 2002541800A5 JP 2000611669 A JP2000611669 A JP 2000611669A JP 2000611669 A JP2000611669 A JP 2000611669A JP 2002541800 A5 JP2002541800 A5 JP 2002541800A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12885899P | 1999-04-12 | 1999-04-12 | |
| US60/128,858 | 1999-04-12 | ||
| PCT/US2000/010039 WO2000061746A1 (en) | 1999-04-12 | 2000-04-12 | 13 transmembrane protein expressed in prostate cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007161935A Division JP2007314543A (ja) | 1999-04-12 | 2007-06-19 | 前立腺癌において発現される１３回膜貫通タンパク質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002541800A JP2002541800A (ja) | 2002-12-10 |
| JP2002541800A5 true JP2002541800A5 (enExample) | 2005-12-15 |
Family
ID=22437339
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000611669A Pending JP2002541800A (ja) | 1999-04-12 | 2000-04-12 | 前立腺癌において発現される１３回膜貫通タンパク質 |
| JP2007161935A Pending JP2007314543A (ja) | 1999-04-12 | 2007-06-19 | 前立腺癌において発現される１３回膜貫通タンパク質 |
| JP2009269211A Pending JP2010051321A (ja) | 1999-04-12 | 2009-11-26 | 前立腺癌において発現される１３回膜貫通タンパク質 |
| JP2012269226A Pending JP2013136574A (ja) | 1999-04-12 | 2012-12-10 | 前立腺癌において発現される１３回膜貫通タンパク質 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007161935A Pending JP2007314543A (ja) | 1999-04-12 | 2007-06-19 | 前立腺癌において発現される１３回膜貫通タンパク質 |
| JP2009269211A Pending JP2010051321A (ja) | 1999-04-12 | 2009-11-26 | 前立腺癌において発現される１３回膜貫通タンパク質 |
| JP2012269226A Pending JP2013136574A (ja) | 1999-04-12 | 2012-12-10 | 前立腺癌において発現される１３回膜貫通タンパク質 |
Country Status (6)
| Country | Link |
|---|---|
| EP (2) | EP1171595A1 (enExample) |
| JP (4) | JP2002541800A (enExample) |
| AU (2) | AU780061B2 (enExample) |
| CA (1) | CA2369413C (enExample) |
| IL (3) | IL145775A0 (enExample) |
| WO (1) | WO2000061746A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7244827B2 (en) * | 2000-04-12 | 2007-07-17 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer |
| US6943235B1 (en) | 1999-04-12 | 2005-09-13 | Agensys, Inc. | Transmembrane protein expressed in prostate cancer |
| JP2004523236A (ja) * | 2001-02-16 | 2004-08-05 | インサイト・ゲノミックス・インコーポレイテッド | 神経伝達関連タンパク質 |
| JP2006508163A (ja) * | 2002-11-27 | 2006-03-09 | アジェンシス， インコーポレイテッド | 癌の処置および検出において有用な２４ｐ４ｃ１２と称される、核酸および対応タンパク質 |
| ES2424745T3 (es) * | 2007-09-07 | 2013-10-08 | Agensys, Inc. | Anticuerpos y moléculas relacionadas que se unen a las proteínas 24P4C12 |
| EP2403524A4 (en) | 2009-03-06 | 2012-09-26 | Agensys Inc | CONJUGATES ANTIBODY-DRUG (ADC) BINDING PROTEINS 24P4C12 |
| JP5122592B2 (ja) * | 2010-01-04 | 2013-01-16 | アジェンシス，インコーポレイテッド | 癌の処置および検出において有用な２４ｐ４ｃ１２と称される、核酸および対応タンパク質 |
| WO2016001485A1 (en) | 2014-06-30 | 2016-01-07 | Glykos Finland Oy | Saccharide derivative of a toxic payload and antibody conjugates thereof |
| US11485972B2 (en) | 2017-05-18 | 2022-11-01 | Modernatx, Inc. | Modified messenger RNA comprising functional RNA elements |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
| US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
| US4870009A (en) | 1982-11-22 | 1989-09-26 | The Salk Institute For Biological Studies | Method of obtaining gene product through the generation of transgenic animals |
| US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
| US4736866A (en) | 1984-06-22 | 1988-04-12 | President And Fellows Of Harvard College | Transgenic non-human mammals |
| EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
| US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
| US5225538A (en) | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
| US5723286A (en) | 1990-06-20 | 1998-03-03 | Affymax Technologies N.V. | Peptide library and screening systems |
| AU8221191A (en) | 1990-06-27 | 1992-01-23 | Princeton University | Probes for detecting mutant p53 |
| US5733731A (en) | 1991-10-16 | 1998-03-31 | Affymax Technologies N.V. | Peptide library and screening method |
| CH686982A5 (fr) | 1993-12-16 | 1996-08-15 | Maurice Stroun | Méthode pour le diagnostic de cancers. |
| EP0773952B1 (en) | 1994-07-20 | 2003-11-12 | The General Hospital Corporation | Interaction trap systems for detecting protein interactions |
| US5919652A (en) | 1994-11-09 | 1999-07-06 | The Regents Of The University Of California | Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof |
| ATE352638T1 (de) | 1995-04-11 | 2007-02-15 | Gen Hospital Corp | REVERSE ßTWO-HYBRIDß-SYSTEME |
| ES2183166T3 (es) | 1996-04-26 | 2003-03-16 | Massachusetts Inst Technology | Ensayo de cribado por triple hibrido. |
| US5925523A (en) | 1996-08-23 | 1999-07-20 | President & Fellows Of Harvard College | Intraction trap assay, reagents and uses thereof |
| WO1998016628A1 (en) | 1996-10-15 | 1998-04-23 | The Regents Of The University Of California | Animal models of human prostate cancer progression |
| US5846722A (en) | 1996-10-16 | 1998-12-08 | Terrapin Technologies, Inc. | System to detect small molecule/peptide interaction |
| EP2305027B1 (en) | 1996-12-03 | 2014-07-02 | Amgen Fremont Inc. | Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom |
| PT1000146E (pt) * | 1997-08-01 | 2006-10-31 | Serono Genetics Inst Sa | Ests 5' para proteinas secretadas sem especificidade tecidular |
| CA2297157A1 (en) * | 1997-08-01 | 1999-02-11 | Genset | 5' ests for secreted proteins expressed in testis and other tissues |
| AU8555198A (en) * | 1997-08-01 | 1999-02-22 | Genset | 5' ests for secreted proteins expressed in prostate |
| CA2328895A1 (en) * | 1998-06-02 | 1999-12-09 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
-
2000
- 2000-04-12 EP EP00922200A patent/EP1171595A1/en not_active Withdrawn
- 2000-04-12 JP JP2000611669A patent/JP2002541800A/ja active Pending
- 2000-04-12 EP EP10185550A patent/EP2365081A3/en not_active Withdrawn
- 2000-04-12 WO PCT/US2000/010039 patent/WO2000061746A1/en not_active Ceased
- 2000-04-12 CA CA2369413A patent/CA2369413C/en not_active Expired - Lifetime
- 2000-04-12 IL IL14577500A patent/IL145775A0/xx unknown
- 2000-04-12 AU AU42425/00A patent/AU780061B2/en not_active Expired
-
2001
- 2001-10-04 IL IL145775A patent/IL145775A/en not_active IP Right Cessation
-
2005
- 2005-05-18 AU AU2005202143A patent/AU2005202143B2/en not_active Expired
-
2007
- 2007-06-19 JP JP2007161935A patent/JP2007314543A/ja active Pending
-
2009
- 2009-11-26 JP JP2009269211A patent/JP2010051321A/ja active Pending
-
2010
- 2010-06-24 IL IL206604A patent/IL206604A/en not_active IP Right Cessation
-
2012
- 2012-12-10 JP JP2012269226A patent/JP2013136574A/ja active Pending